A Comparative Study Between Laryseal Pro Extraglottic Device and Ambu Aura Gain Laryngeal Mask as a Conduit for Fiberoptic Tracheal Intubation in Pediatric Population
A Comparative Study Between Laryseal Pro Extraglottic Device and Ambu Aura Gain Laryngeal Mask as a Conduit for Fiberoptic Tracheal Intubation in Pediatric Population: A Prospective Randomized Controlled Study
Cairo University
100 participants
Apr 15, 2025
INTERVENTIONAL
Conditions
Summary
This study aims to compare between Laryseal Pro and Ambu Aura Gain extraglottic devices as conduits for fiberoptic endotracheal intubation regarding time of endotracheal intubation in pediatric population.
Eligibility
Inclusion Criteria5
- Age starting from 4 years to 8 years.
- Both genders.
- ASA physical status class I-ll.
- Apparently anatomically normal with normal percentile growth chart, not suspected to have difficult airway.
- Scheduled for day case surgeries more than one hour under general anesthesia.
Exclusion Criteria6
- Parents refusal.
- Abnormality in head and neck or craniofacial anomalies as Piere Robbin syndrome, facial trauma, head and neck tumours, swellings and hemangiomas.
- Patients at risk of regurgitation and pulmonary aspiration such as patients with hiatus hernia, GERD or DM.
- Abnormal or contraindicated cervical spine flexion/extension/rotation.
- Allergy to any EAD components.
- Any active respiratory or cardiac disease and metabolic disorders.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
compare between Laryseal Pro and Ambu Aura Gain extraglottic devices as conduits for fiberoptic endotracheal intubation regarding time of endotracheal intubation in pediatric population.
compare between Laryseal Pro and Ambu Aura Gain extraglottic devices as conduits for fiberoptic endotracheal intubation regarding time of endotracheal intubation in pediatric
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06945029